Recent studies using AAV-CRISPR/Cas9 have successfully corrected mutations in the insulin receptor gene in inducible knockout mice, improving insulin sensitivity and glycemic control, which underscores the translational potential of in vivo gene editing for T2D-related genetic defects [32]. Here, INS is linked to type 2 diabetes mellitus.